89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 69 filers reported holding 89BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $781,666 | -19.3% | 50,626 | -0.9% | 0.00% | – |
Q2 2023 | $968,364 | +32178.8% | 51,101 | +6131.8% | 0.00% | – |
Q1 2022 | $3,000 | -72.7% | 820 | 0.0% | 0.00% | – |
Q4 2021 | $11,000 | -31.2% | 820 | 0.0% | 0.00% | – |
Q3 2021 | $16,000 | +6.7% | 820 | 0.0% | 0.00% | – |
Q2 2021 | $15,000 | -31.8% | 820 | -10.9% | 0.00% | – |
Q1 2021 | $22,000 | -4.3% | 920 | -3.5% | 0.00% | – |
Q4 2020 | $23,000 | +15.0% | 953 | +23.8% | 0.00% | – |
Q3 2020 | $20,000 | +150.0% | 770 | +86.9% | 0.00% | – |
Q2 2020 | $8,000 | -20.0% | 412 | +1.0% | 0.00% | – |
Q1 2020 | $10,000 | -37.5% | 408 | -32.1% | 0.00% | – |
Q4 2019 | $16,000 | – | 601 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |